Cara Therapeutics, Inc. (CARA) has seen some recent action in the stock market and its stock finished trading at $13.26 yesterday. People are starting to take notice of CARA as the stock traded as high as $13.58 and as low as $13.10 in the last market day.

Cara Therapeutics, Inc. (CARA) average trading volume is 395.77K. However, in the last market day Cara Therapeutics, Inc. (CARA) traded 328,019 shares. The First support level on CARA is $13.08 and the First upside resistance level on CARA is $17.91. CARA fifty day moving average is $13.81 and CARA 200 day moving average is $15.59.

Cara Therapeutics, Inc. (CARA) current performance has been indicated by the recent movement in CARA stock. CARA has performed 4.08% over the past 4 weeks, CARA has performed -22.66% over the past 3 months and CARA has shown -36.13% over the past year. Cara Therapeutics, Inc. (CARA) has a 52 week range of $8.88 to $26.67. Cara Therapeutics, Inc. (CARA) is trading 49.32% from its 52 week low and -50.28% from its 52 week high. Cara Therapeutics, Inc. (CARA) is showing a 11.64% short float showing the amount short in the float.

CARA has 46.80M shares outstanding and 38.85M shares in the float. Cara Therapeutics, Inc. (CARA) currently has a market cap of $617.52M and income of -115.40M. The EPS next quarter for CARA is -0.60 and anticipated EPS next year is 11.10%. The market cap of Cara Therapeutics, Inc. (CARA) at $617.52M signifies how many People own shares of CARA and is based off the last price ($13.26) of CARA and the amount of shares outstanding (46.80M) with Cara Therapeutics, Inc. (CARA).

Cara Therapeutics, Inc. (CARA) has total cash (mrq) of 130.19M, total cash per share (mrq) of 2.78, total debt of CARA stands at 3.96M and total debt/equity (mrq) is 2.81. . Cara Therapeutics, Inc. (CARA) operational cash flow (ttm) is -122.76M, CARA leveraged free cash flow (ttm) is -78.36M.

CARA is trading -4.02% below (bearish) its SMA20, -7.59% below (bearish) its SMA50 and -13.57% below (bearish) its SMA200.